BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for viacord

PerkinElmer Pairs Whole Genome Sequencing with Cord Blood and Tissue Banking

By

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Provides Families a Novel, Personalized Approach to Managing their Health

WALTHAM, Mass.–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction of its clinical WGS services.

PerkinElmer Viacord Whole Genome Sequencing

Parents that choose ViaCord, PerkinElmer’s cord blood and cord tissue preservation business, now have the opportunity to benefit from a physician-ordered WGS test of their child’s DNA via a simple saliva test. The test examines a broad range of disease-related genes and provides diagnostic findings contributing to pediatric onset diseases. Additionally, the test reports on pharmacogenetic variants used to optimize certain drug selection.
[Read more…]

Power of Strategic Alliances within the Cord Blood Banking Industry

By

A growing phenomenon wihtin the cord blood industry is the use of strategic alliances. This is not surprising, because it is valuable for cord blood banks to establish collaborative relationships with doctors, hospitals, birthing centers, insurance companies, government entities, medical researchers, public and private donors, and more. However, the terms and scope of key strategic alliances within the cord blood industry are often kept quiet. Other times, the partnerships are well-known within a specific region, but not publicized on a global basis.

For this reason, five key alliances that substantially impact the cord blood industry are explored below. [Read more…]

Human Longevity Inc. Expands Role in Newborn Genome Sequencing with Strategic Acquisition of LifebankUSA from Celgene

By

In major news released today, Human Longevity, Inc. (HLI) announced that is is acquiring LifebankUSA, a cord blood, placental blood, and tissue bank owned by Celegene Cellular Therapeutics, a move that will position HLI to offer its newborn genome sequencing product in combination with stem cell banking services.

To learn more about the acquisition, read the full press release from Human Longevity, Inc. below.

Or, read our recent article exploring how this move will provide HLI with increased access to prenatal, neonatal, and maternal health markets, similar to the access that AMAG Pharmaceutical gained through its acquisition of Cord Blood Registry and PerkinElmer gained through its acquisition of ViaCord. [Read more…]

Human Longevity, Inc. to Expand Reach into Neonatal & Maternal Health Markets by Acquiring Celgene Owned LifebankUSA

By

In major news released today, Human Longevity, Inc. (HLI) announced that is is acquiring LifebankUSA, a cord blood, placental blood, and tissue bank owned by Celgene Cellular Therapeutics.

Based in San Diego, CA, Human Longevity, Inc. is an innovative company that specializes in the use of whole genome sequence analysis, clinical imaging, and machine learning to extend health across a longer human lifespan. LifebankUSA, based in Cedar Knolls, NJ, is the “the only company that offers cord blood, placenta blood and tissue banking – and the first to release placenta-derived stem cells for a successful transplant.” Celgene Cellular Therapeutics (CCT), the parent company of LifeBankUSA, specializes in cell therapy and regenerative medicine products, using LifeBankUSA to source its cell therapy, organ and tissue products, several of which are now being explored in clinical trials (PDA001, PDA002, and others).

The move will position Human Longevity, Inc. to offers its newborn genome sequencing product in combination to its newly acquired stem cell banking services.
 [Read more…]

ViaCord Finds Ultimate Solution to Cord Blood Marketing – Aligns with the World’s Largest Retailer of Maternity Clothing

By

An interesting partnership within the cord blood marketplace is between the second largest cord blood bank in the world, ViaCord, and the world’s largest designer and retailer of women’s maternity clothing, Destination Maternity. Headquartered in Philadelphia, Pennsylvania, USA, Destination Maternity operates 2,008 retail locations, including 625 stores, largely under the trade names Destination Maternity, Motherhood Maternity, and A Pea in the Pod.[1]

Based on the lack of competing offers, ViaCord appears to have exclusive rights to have its cord blood banking educational materials placed in the checkout bags of clients purchasing maternity items at Destination Maternity retail stores. [Read more…]

BioInformant's World-Class Clients